May 13, 2020
ALung Technologies Founder Bill Federspiel and CEO Pete DeComo talk about the 23 year path of building the company. ALung Technologies is a pioneer in the development of respiratory assist technologies that provide a superior alternative to traditional, invasive respiratory support.
Bill is on faculty in the Swanson School of Engineering and the McGowan Institute. Pete successful scaled and sold Renal Solutions in Pittsburgh.
ALung is commercializing the Hemolung Respiratory Assist System (RAS) for the benefit of patients and their caregivers. It is now being used to treat patients with COVID-19.
Hemolung RAS is a safe and simple-to-use respiratory assist system that can replace mechanical ventilation in a majority of respiratory exacerbation cases or provide a supplement that can lessen lengths of stay on mechanical ventilation and in the ICU. The dialysis-like system effectively supplements lung function through a single, small catheter, removing 50 percent of retained carbon dioxide from the blood, while administering up to 25 percent oxygen.